High mRNA expression level of IL-6R was associated with better prognosis for patients with ovarian cancer: a pooled meta-analysis.

about

High mRNA expression level of IL-6R was associated with better prognosis for patients with ovarian cancer: a pooled meta-analysis.

Item

http://www.wikidata.org/entity/Q40077912

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

High mRNA expression level of ...... ancer: a pooled meta-analysis.

@en

type

Item

label

High mRNA expression level of ...... ancer: a pooled meta-analysis.

@en

prefLabel

High mRNA expression level of ...... ancer: a pooled meta-analysis.

@en

P1476

High mRNA expression level of ...... ancer: a pooled meta-analysis.

@en

P2093

Bin Xu

http://www.w3.org/2001/XMLSchema#string

Binfeng Lu

http://www.w3.org/2001/XMLSchema#string

Da Yang

http://www.w3.org/2001/XMLSchema#string

Jingting Jiang

http://www.w3.org/2001/XMLSchema#string

Lei Lan

http://www.w3.org/2001/XMLSchema#string

Min Yang

http://www.w3.org/2001/XMLSchema#string

Qu Chen

http://www.w3.org/2001/XMLSchema#string

Yueping Shen

http://www.w3.org/2001/XMLSchema#string

P2860

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array.

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.

Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets.

The role of cytokines in both the normal and malignant ovary.

The soluble IL-6 receptors: serum levels and biological function.

Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.

Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer.

Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer.

Interleukin-6 as a therapeutic target in human ovarian cancer

P2888

s41598-017-09333-8

P304

8769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1038/S41598-017-09333-8

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28821817

http://www.w3.org/2001/XMLSchema#string

P932

5562889

http://www.w3.org/2001/XMLSchema#string